FIELD: pharmaceutical chemistry. SUBSTANCE: invention provides novel cephalosporin derivatives of general formulas I and II: (I) and (II), wherein R1 is selected from group including -NHC(O)ZR3 and -NR4R5, Z denotes -CH2(X)m or -C(NOR6), X sulfur atom, m= 0-1; R3 denotes thiazolyl group substituted by chlorine atom or amino group or (CH2)T, in which n=1-6, T is guanidine group; R4 and R5 each denotes hydrogen atom; R6 hydrogen atom or group forming with adjacent oxygen atom protected hydroxyl group; R2 hydrogen atom; each of G, H, L, and M denotes carbon atom; J nitrogen atm; rings A, B, D, and E are selected from group including thiazolyl and thiadiazolyl; R11 denotes hydrogen atom; alk1 is C1-C6-alkyl; alk2 is C1-C6-alkyl optionally substituted by hydroxyl, amino, or carboxamido group; p= 0-1; R99 is sulfur atom or SO2 group; q=1; r=1-3; R12 denotes group NR13R14, group a: (a), or group b: (b); R13-R17 each denotes hydrogen atom; or their pharmacologically acceptable salts. Antibacterial composition possessing activity against methicillinum-, vancomycin-, and ampicillinum- resistant bacteria includes pharmaceutically acceptable vehicle and effective amount of compound of formula I or II or its salt. Aminothiazole of general formula III: (III), in which Pg1 is hydrogen atom or triphenylmethyl and Pg2 is triphenylmethyl is prepared by reaction of compound IIIa: (IIIa) with chlorination agent in organic solvent. EFFECT: enlarged choice of cephalosporin derivatives. 25 cl, 5 dwg, 2 tbl, 140 ex
Title |
Year |
Author |
Number |
PRODRUGS OF ANTIBIOTIC 7-ACYLAMINO-3-HETEROARYLTHIO-3-CEPHEM CARBOXYLIC ACID |
2001 |
- Ehkker Skott Dzh.
- Cho Aehsop
- Glinka Tomas V.
- Kolkins Trevor
- Li Ving Dzh.
|
RU2279435C2 |
DERIVATIVES OF 7-ACYLAMINO-3-HETEROARYLTHIO-3-CEPHEM CARBOXYLIC ACID AND ANTIBACTERIAL COMPOSITIONS COMPRISING THEREOF |
2000 |
- Khekker Skott Dzh.
- Cho Aehsop
- Glinka Tomas V.
- Kolkinz Trevor
- Li Ving Dzh.
|
RU2225868C2 |
DERIVATIVES OF THIOALKYLTHIOCEPHALOSPORIN OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, ANTIBACTERIAL COMPOSITION |
1991 |
- Tadatosi Kubota[Jp]
- Masakharu Kume[Jp]
|
RU2071963C1 |
METHOD OF PRODUCING DERIVATIVES OF CEPHEM OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
0 |
- Akio Miyake
- Masakhiro Kondo
- Masakhiro Fudzino
|
SU1538898A3 |
METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES |
2002 |
- Makichern Ehrnest Dzh.
- Bridzher Gari Dzh.
- Skupinska Kristina A.
- Skerldzh Renato T.
|
RU2308451C2 |
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND USE THEREOF AS PROTEIN KINASE INHIBITOR |
2007 |
- Birss Dehvid Dzh.
- Lju Sjao-Khoj
- Vankajalapati Khariprasad
- Sjuj Jun
|
RU2487875C2 |
NOVEL COMPOUNDS AS CATHEPSIN INHIBITORS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHOD FOR THEIR PREPARING |
2002 |
- Graup Majkl
- Palmer Dzhejms T.
- Ehldos Dehvid Dzh.
- Turajratnam Sukantini
|
RU2316546C2 |
METHOD OF PRODUCING CEFEM DERIVATIVES OR THEIR SALTS |
0 |
- Akio Miyake
- Masakhiro Kondo
- Masakhiro Fudzino
|
SU1595341A3 |
2,7-SUBSTITUTED DERIVATIVES OF OCTAHYDRO-1H-[1,2-A]-PYRAZINE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF BINDING DOPAMINE WITH DOPAMINE D RECEPTOR |
1995 |
- Kishor A. Desaj
- Ehnton F. Dzh. Fliri
- Mark A. Sehnner
|
RU2163239C2 |
DERIVATIVES OF DIAZEPINE, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENTS WITH ARRYTHMIA |
1994 |
- Dzhon Dzh. Boldvin
- Dehvid A. Klehrimon
- Dzhejson M. Ehlliot
- Nigel Liverton
- Dehvid K. Remi
- Garol'D G. Selnik
|
RU2155587C2 |